News on Hepatitis continually updated from thousands of sources around the net.
1 hr ago | The New Zealand Herald
Maintaining the momentum of scientific discoveries and breakthroughs is critical to preventing further HIV infections, improving care for the 35 million people living with HIV and because other critical global health priorities compete for funding in our fiscally-constrained world.
Trending on the Topix Network
2 hrs ago | The Telegraph
Imphal, July 10: The Hepatitis-C co-infection among drug users and people living with HIV in Manipur has become a serious health problem with the state government groping in the dark to tackle the situation, experts said.
3 hrs ago | The Las Vegas Sun
In a split decision, the Nevada Supreme Court ruled today that a Las Vegas man cannot sue a health maintenance organization for sending him to the clinic where there was an outbreak of hepatitis in 2008.
4 hrs ago | The Bennington Banner
More than 600 Vermonters have chronic hepatitis C. The disease was the second most commonly tracked by public health officials last year, according to data from the Vermont Department of Health.
6 hrs ago | PhysOrg Weblog
France said Thursday it has joined forces with 13 other European countries to negotiate a lower price for a promising new hepatitis C drug that has drawn controversy for its astronomical cost.
10 hrs ago | The Jersey Journal
Su Wang, medical director of The Center for Asian Health at Saint Barnabas, in her West Orange office.
14 hrs ago | HIV and Hepatitis
Bristol-Myers Squibb's all-oral dual regimen of daclatasvir plus asunaprevir has been approved for the treatment of chronic hepatitis C in Japan, where most people are infected with HCV genotype 1b, the company announced this week.
Since introduction of its new breakthrough drug Sovaldi, which comes close to "curing" Hepatitis C, Gilead has been under intense public scrutiny because the three-month course of therapy "is too expensive."
A North Carolina-based, company-owned Papa John's location has been identified as the original source of a hepatitis A outbreak that happened in late March/early April.
Chronic disease develops in 60-85% of patients, with cirrhosis representing a major hallmark of HCV infection.
The following quote was obtained by the news editors from the background information supplied by the inventors: "Previously, non-alcoholic fatty liver disease was believed to be a benign disease that does not progress.
According to a new market report published by Transparency Market Research "Safety Syringes Market Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 - 2019," the global safety syringes market was valued at USD 3.41 billion in 2012 and is expected to grow at a CAGR of 9.7% from 2013 to 2019, to reach an estimated value ... (more)
Last month, the FDA took a much-anticipated step by issuing guidelines for drug makers that want to use social media, including examples of how to run paid search links on Google.
The trial manuscript, entitled "The Fatty Acid-Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients with Nonalcoholic Fatty Liver Disease," provides the full report of the Phase IIa trial, which was completed in and presented at the 47th Annual Meeting of the European Association for the Study of the Liver in 2012.
Cabarrus and Mecklenburg county leaders said Papa John's restaurant owes them money after they stepped in to help with a hepatitis A scare.
Millions of people throughout the world are infected with hepatitis C virus . Left untreated, infection results in serious complications such as cirrhosis of the liver and cancer.
Before the term "vaccination" was coined, millions died every year from infectious diseases such as smallpox, tuberculosis and yellow fever.
Updated: Thu Jul 10, 2014 04:49 pm
Copyright © 2014 Topix LLC